Literature DB >> 18205970

Balloon angioplasty is preferred to surgery for aortic coarctation.

Derek Wong1, Lee N Benson, Glen S Van Arsdell, Tara Karamlou, Brian W McCrindle.   

Abstract

OBJECTIVE: We sought to use techniques of decision analysis to compare values or preferences for balloon angioplasty versus surgery for treatment of aortic coarctation in children.
BACKGROUND: Balloon angioplasty and surgery for aortic coarctation have a differing spectrum and prevalence of outcomes and complications, making direct comparison difficult.
METHODS: From articles reporting treatment outcomes of native aortic coarctation from 1984 through 2005, we determined the baseline probabilities of successful treatment, complications, recoarctation and aneurysmal formation. Decision trees with baseline probabilities of these outcomes were formulated. Standard gamble interviews of medical professionals determined the preferences for the various outcomes. Final cumulative preference scores were further adjusted for both perceived mortality and procedural disutility. Sensitivity analyses determined threshold probabilities at which the score advantage changed.
RESULTS: Final preference scores for balloon angioplasty, with a mean of 0.8999, and standard deviation of 0.0236, were significantly higher than for surgery, at a mean of 0.8873, and standard deviation of 0.0246. The score advantage for balloon angioplasty did not change when adjusted for disutility, or mortality. Sensitivity analysis showed that even if the probability of periprocedural death or major complications for surgery was reduced to none, balloon angioplasty would still be preferred, expect for neonates, where if surgical mortality were reduced below 4%, then surgery would be preferred. Probabilities for periprocedural death or major complications associated with balloon angioplasty would have to exceed plausible thresholds before surgery would be preferred.
CONCLUSIONS: After accounting for preference-weighted probabilities of outcomes, balloon angioplasty is preferred over surgery for all plausible situations as the initial treatment for native aortic coarctation in children.

Entities:  

Mesh:

Year:  2008        PMID: 18205970     DOI: 10.1017/S1047951107001795

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  7 in total

Review 1.  Surgical, interventional, and device innovations in the management of hypertension.

Authors:  Sibu P Saha; Khaled M Ziada; Thomas F Whayne
Journal:  Int J Angiol       Date:  2015-03

Review 2.  Coarctation repair-redo challenges in the adults: what to do?

Authors:  Erik Beckmann; Arminder S Jassar
Journal:  J Vis Surg       Date:  2018-04-23

3.  Multiple transcatheter interventions in the same session in congenital cardiopathies.

Authors:  Saritas Turkay; Erdem Abdullah; Akdeniz Celal; Zeybek Cenap; Erol Nurdan; Demir Fadli; Demir Halil; Aydemir Numan Ali; Celebi Ahmet
Journal:  J Cardiovasc Dis Res       Date:  2010-10

4.  Isolated Coarctation of the Aorta: Current Concepts and Perspectives.

Authors:  Ami B Bhatt; Maria R Lantin-Hermoso; Curt J Daniels; Robert Jaquiss; Benjamin John Landis; Bradley S Marino; Rahul H Rathod; Robert N Vincent; Bradley B Keller; Juan Villafane
Journal:  Front Cardiovasc Med       Date:  2022-05-25

Review 5.  Coarctation of the aorta - the current state of surgical and transcatheter therapies.

Authors:  Jeffrey E Vergales; James J Gangemi; Karen S Rhueban; D Scott Lim
Journal:  Curr Cardiol Rev       Date:  2013-08

6.  Percutaneous balloon angioplasty for severe native aortic coarctation in young infants less than 6 months: medium- to long-term follow-up.

Authors:  Lan He; Fang Liu; Lin Wu; Chun-Hua Qi; Li-Feng Zhang; Guo-Ying Huang
Journal:  Chin Med J (Engl)       Date:  2015-04-20       Impact factor: 2.628

7.  Effect of coarctation of aorta anatomy and balloon profile on the outcome of balloon angioplasty in infantile coarctation.

Authors:  Hamid Amoozgar; Narjes Nouri; Sajad Shabanpourhaghighi; Neda Bagherian; Nima Mehdizadegan; Mohammad Reza Edraki; Amir Naghshzan; Hamid Mohammadi; Gholamhossein Ajami; Ashkan Abdollahi
Journal:  BMC Cardiovasc Disord       Date:  2021-12-15       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.